TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1589410

Group type: COMPARATOR
Intervention: Nasal spray formulation without STDHF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal formulations containing 3% (w/v) of STDHF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal formulations containing 1.65% (w/v) of STDHF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal formulations containing 1.2% (w/v) of STDHF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal formulations containing 0.8% (w/v) of STDHF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All STDHF-containing sprays
Number of subjects: 0
Study: 3890600

Group type: EXPERIMENTAL
Intervention: terbutaline delivered by a pressurized aerosol with a tube spacer (TS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: salbutamol from a dry powder inhaler (Rotahaler = RO)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: tube spacer (TS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 2957205

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 26

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 26
Study: 30336205

Group type: EXPERIMENTAL
Intervention: Intensive Glycemic Control (IGC; HbA1c target < 6.0%)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard Glycemic Control (SGC; HbA1c target 7.0% to 7.9%)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Mean HbA1c
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Post-randomization mean HbA1c
Number of subjects: 124
Study: 27893539

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pulsed Dye Laser (PDL) treatment
Number of subjects: 30
Study: 26131788

Group type: EXPERIMENTAL
Intervention: Mobile training video for explosives scenario
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mobile training video for chemical nerve agent scenario
Number of subjects: 90

Group type: COMPARATOR
Intervention: Radiologic scenario (no intervention)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cognitive posttest scores
Number of subjects: 90
Study: 23130943

Group type: EXPERIMENTAL
Intervention: Auricular acupressure applied to six true acupoints (shenmen, Kidney, Liver, Internal Genitals, Central Rim, and Endocrine) for 1 minute, 4 times a day for 2 days.
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sham acupressure applied to six sham acupoints for 1 minute, 4 times a day for 2 days.
Number of subjects: 113
Study: 21134121

Group type: EXPERIMENTAL
Intervention: 5u/mL BTX‐A
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 60
Study: 18227701

Group type: EXPERIMENTAL
Intervention: Self-reported freckling when sunbathing
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported sunbathing vacations to southern latitudes
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported solarium use in the last 5 years
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported sunscreen use (yes/no) on specific occasions
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported SPF on sunbathing vacations to southern latitudes (today)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported SPF on sunbathing vacations to southern latitudes (10 years ago)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported sunscreen brand use (yes/no)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported SPF for sunscreen brands
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported frequency of sunburn
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-reported frequency of sunbathing vacations in Norway or outside southern latitudes
Number of subjects: 2000
Study: 16513202

Group type: EXPERIMENTAL
Intervention: Morning insulin glargine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Bedtime NPH
Number of subjects: 62
Study: 12948920

Group type: COMPARATOR
Intervention: 0.005% calcipotriol alone once daily (monotherapy)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 0.004% calcipotriol/0.01% clobetasol propionate as a premixed ointment once daily (combination therapy)
Number of subjects: 61
Study: 10784636

Group type: EXPERIMENTAL
Intervention: Finasteride (intervention group)
Number of subjects: 18882
Study: 9182470

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 1586684

Group type: EXPERIMENTAL
Intervention: O-System (OS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: System II (CS)
Number of subjects: 60
Study: 3897499

Group type: EXPERIMENTAL
Intervention: Intermittent lumbar punctures
Number of subjects: 47

Group type: COMPARATOR
Intervention: Supportive care only (Control)
Number of subjects: 47
Study: 30649257

Group type: EXPERIMENTAL
Intervention: Piezocision (surgical protocol with sutures)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (without any further treatment)
Number of subjects: 24
Study: 29562486

Group type: EXPERIMENTAL
Intervention: New cold modality targeting upper normal therapeutic temperature range
Number of subjects: 53

Group type: COMPARATOR
Intervention: Ice pack therapy
Number of subjects: 53
Study: 27573936

Group type: COMPARATOR
Intervention: THCV (5 mg twice daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: CBD (100 mg twice daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Combination treatments (1:1 ratio of CBD and THCV (5 mg/5 mg, twice daily) and 20:1 ratio of CBD and THCV (100 mg/5 mg, twice daily))
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 26302251

Group type: EXPERIMENTAL
Intervention: Bounce Back intervention (10-session cognitive-behavioral group intervention)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Delayed intervention (3-month waitlist)
Number of subjects: 74
Study: 23809278

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 30 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) 1.5 mg
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) 1.5 mg + meloxicam 15 mg
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 20884177

Group type: EXPERIMENTAL
Intervention: Nifedipine CR 40 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Diltiazem R 100 mg
Number of subjects: 37
Study: 18203086

Group type: EXPERIMENTAL
Intervention: Latanoprost-timolol maleate fixed combination (LTFC) administered at 8 PM (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Latanoprost-timolol maleate fixed combination (LTFC) administered at 8 AM (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Latanoprost therapy alone (Control)
Number of subjects: 30
Study: 16369463

Group type: EXPERIMENTAL
Intervention: 8-weeks of RR training using audiotapes (n=34)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Health-education control condition (n=12)
Number of subjects: 46
Study: 12698048

Group type: EXPERIMENTAL
Intervention: Lowering of intraocular pressure (IOP) by 30% or more
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lowering of IOP
Number of subjects: 0
Study: 10698329

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX/A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9524791

Group type: EXPERIMENTAL
Intervention: Intramuscular meloxicam (15 mg) on Day 1 followed by oral meloxicam (15 mg/day) for 7 days
Number of subjects: 169

Group type: COMPARATOR
Intervention: Intramuscular piroxicam (20 mg) on Day 1 followed by oral piroxicam (20 mg/day) for 7 days
Number of subjects: 169
Study: 1283411

Group type: EXPERIMENTAL
Intervention: Modified technique for the Gillies temporal approach without hair removal
Number of subjects: 2

Group type: COMPARATOR
Intervention: Modified technique for the Gillies temporal approach with hair removal
Number of subjects: 2
Study: 3513719

Group type: EXPERIMENTAL
Intervention: Three injection regimen (delaying evening intermediate acting insulin to bedtime)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional insulin regimen (evening intermediate acting insulin before the evening meal)
Number of subjects: 18
Study: 30585526

Group type: EXPERIMENTAL
Intervention: Primary radical prostatectomy (RP) with extended pelvic lymph-node dissection and adjuvant or salvage radiation therapy (RT) and/or androgen deprivation therapy (ADT) if deemed necessary.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Primary radiation treatment (RT) plus androgen deprivation treatment (ADT).
Number of subjects: 400
Study: 27004726

Group type: EXPERIMENTAL
Intervention: Experimental regimen (3 or 4 months duration)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: STEP trial with 80 patients per arm
Number of subjects: 80
Study: 25769201

Group type: EXPERIMENTAL
Intervention: TightRope fixation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Syndesmotic screw fixation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 43
Study: 24392223

Group type: EXPERIMENTAL
Intervention: intensive counseling plus smartphone intervention
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: less intensive counseling plus smartphone intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: intensive counseling intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: smartphone intervention only
Number of subjects: 68
Study: 20406214

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 ml t.i.d. for 5 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 12
Study: 17965148

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg single-dose
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 15974146

Group type: EXPERIMENTAL
Intervention: CD-ROM preventive intervention (n = 61)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (n = 62)
Number of subjects: 123
Study: 12754171

Group type: EXPERIMENTAL
Intervention: Hyperthermia trial
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial
Number of subjects: 8
Study: 10368494

Group type: EXPERIMENTAL
Intervention: Vaginal estradiol (2 mg twice daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral estradiol (2 mg twice daily)
Number of subjects: 10
Study: 8694680

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 2015735

Group type: EXPERIMENTAL
Intervention: Triazolam, 0.5 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Temazepam, 30 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 7089798

Group type: EXPERIMENTAL
Intervention: Coffee (active drug)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decaffeinated coffee (placebo)
Number of subjects: 0
Study: 29781308

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone injection
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol ointment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 28317683

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-created CCI
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual CCI
Number of subjects: 20
Study: 26134462

Group type: EXPERIMENTAL
Intervention: Standing position breathing exercises with positive expiratory pressure
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sitting position breathing exercises with positive expiratory pressure
Number of subjects: 189
Study: 23817976

Group type: EXPERIMENTAL
Intervention: Motor rTMS sessions for 2 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham rTMS sessions for 2 weeks
Number of subjects: 18
Study: 21763211

Group type: EXPERIMENTAL
Intervention: Duloxetine treatment
Number of subjects: 797
Study: 18437470

Group type: EXPERIMENTAL
Intervention: Encouragement to resume daily physical activity with standardized advice and individualized activity goals
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Encouragement to resume daily physical activity
Number of subjects: 64
Study: 16920590

Group type: EXPERIMENTAL
Intervention: 24-hour head bandage
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10-day head bandage
Number of subjects: 80
Study: 15241710

Group type: EXPERIMENTAL
Intervention: Heading group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Kicking group
Number of subjects: 31
Study: 11408507

Group type: EXPERIMENTAL
Intervention: HEC (epirubicin 100 mg/m², cyclophosphamide 830 mg/m²; day 1 every 3 weeks)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: EC (epirubicin 60 mg/m², cyclophosphamide 500 mg/m²; day 1 every 3 weeks)
Number of subjects: 255

Group type: COMPARATOR
Intervention: CMF (oral cyclophosphamide for six cycles)
Number of subjects: 255
Study: 9208358

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg once daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Captopril (75 mg thrice daily)
Number of subjects: 27
Study: 7778531

Group type: EXPERIMENTAL
Intervention: Delapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study: 2399180

Group type: EXPERIMENTAL
Intervention: Chloral hydrate (50 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diazepam (0.6 mg/kg)
Number of subjects: 30
Study: 386715

Group type: EXPERIMENTAL
Intervention: 6 g L-tryptophan daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: 150 mg imipramine daily
Number of subjects: 58
Study: 31113177

Group type: EXPERIMENTAL
Intervention: Strength Training Group (STG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 28
Study: 28100544

Group type: EXPERIMENTAL
Intervention: Oscillatory whole-body vibration (WBV) - 16 sessions of 1-hour duration within 4 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oscillatory whole-body vibration (WBV)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined analysis of all patients (n=22)
Number of subjects: 22
Study: 25049195

Group type: EXPERIMENTAL
Intervention: Treatment focusing on weight and behavioral symptoms
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment focusing solely on improving QoL
Number of subjects: 63
Study: 24938369

Group type: EXPERIMENTAL
Intervention: Menthol smoking
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Non-menthol smoking
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Menthol smoking (AA women)
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Menthol smoking (white women)
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Menthol smoking (AA males)
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Menthol smoking (white males)
Number of subjects: 1439
Study: 23174473

Group type: EXPERIMENTAL
Intervention: Running group (30 minutes of running every morning at moderate intensity for 3 weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 21056284

Group type: EXPERIMENTAL
Intervention: Orange juice (OJ) concentrate, 750 mL/day for 60 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no OJ consumption for 60 days)
Number of subjects: 45
Study: 17599421

Group type: EXPERIMENTAL
Intervention: Intensive-care guidelines
Number of subjects: 2977

Group type: COMPARATOR
Intervention: Standard-care guidelines
Number of subjects: 2977

Group type: EXPERIMENTAL
Intervention: Full-brain magnetic resonance imaging
Number of subjects: 2977
Study: 15699477

Group type: EXPERIMENTAL
Intervention: gefitinib 250 mg/d
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: gefitinib 500 mg/d
Number of subjects: 216
Study: 11969355

Group type: EXPERIMENTAL
Intervention: Intervention group (breast screening intervention program delivered by lay health educators)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Intervention group (with significant others providing information/help)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (with significant others providing information/help)
Number of subjects: 325
Study: 9032097

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin therapy (IP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Multiple daily insulin injections (MDI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nondiabetic control subjects
Number of subjects: 22
Study: 7822993

Group type: EXPERIMENTAL
Intervention: Education on diagnostic tests, chart audit, and feedback provided twice a week for first and second year residents; peer-review strategy for staff.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (R2C)
Number of subjects: 36
Study: 3555162

Group type: EXPERIMENTAL
Intervention: 0.2 mg epinephrine added to hyperbaric spinal bupivacaine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Hyperbaric spinal bupivacaine without epinephrine
Number of subjects: 63
Study: 29318430

Group type: EXPERIMENTAL
Intervention: 1.5-T MRI in cPM/cICD carriers (study group, SG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Non-cardiac MRI in cPM/cICD carriers (study group, SG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cardiac MRI in cPM carriers (study group, SG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cardiac MRI in cICD carriers (study group, SG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chest x-ray, CT or follow-up (reference group, RG)
Number of subjects: 120
Study: 27857633

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ischemic Compression (IC)
Number of subjects: 31
Study: 25135124

Group type: EXPERIMENTAL
Intervention: 3 mg of oral melatonin administered at 9:00 pm for four consecutive days
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo administered at 9:00 pm for four consecutive days
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 3 mg of oral melatonin
Number of subjects: 198
Study: 22994519

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High altitude (HA) exposure
Number of subjects: 23
Study: 19933916

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy (3 or 4 cycles)
Number of subjects: 1867
Study: 18812366

Group type: EXPERIMENTAL
Intervention: Installation of a non‐polluting, more effective home heater
Number of subjects: 409
Study: 16157231

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Gabapentin (0 and 600 mg/day)
Number of subjects: 8
Study: 12147851

Group type: EXPERIMENTAL
Intervention: Endovascular irradiation with a (192)Ir source (14 Gy 2 mm deep to the vessel wall)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No irradiation (control group)
Number of subjects: 30
Study: 10436249

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg twice daily)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 217
Study: 7749088

Group type: EXPERIMENTAL
Intervention: MRI with extreme T2 weighting (TR 5950 ms, TE 150 ms)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MRI with T2 weighting
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Quantifying a grey scale to demonstrate early marrow oedema
Number of subjects: 49
Study: 1932484

Group type: EXPERIMENTAL
Intervention: Intravenous famotidine (10 mg bolus followed by a constant infusion of 3.2 mg/h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (similarly administered)
Number of subjects: 20
Study: 7136659

Group type: EXPERIMENTAL
Intervention: Expressed human milk for all feeds
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Human milk for half the feeds and nursery formula for the rest
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Colostrum, 20 ml three times a day along with nursery formula
Number of subjects: 261

Group type: COMPARATOR
Intervention: Nursery formula only
Number of subjects: 261
Study: 30430667

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation therapy for 20 min and oral health education for 15 min before periodontal treatment once per week for 4 wk
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral health education only for the same duration
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral health education only
Number of subjects: 68
Study: 29933364

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 26898569

Group type: EXPERIMENTAL
Intervention: Mesalazine modified-release tablets (MR group, n = 123)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Mesalazine enteric-coated tablets (EC group, n = 128)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Mesalazine modified-release tablets (MR group)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Mesalazine enteric-coated tablets (EC group)
Number of subjects: 251
Study: 24808486

Group type: EXPERIMENTAL
Intervention: High-dairy condition (+4 servings conventional nonfat dairy products/d)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-dairy condition (+4 servings fruit products/d)
Number of subjects: 49
Study: 23034968

Group type: EXPERIMENTAL
Intervention: HFrAA (6.77 g of a mixture of 5 essential amino acids 3 times/d)
Number of subjects: 9

Group type: COMPARATOR
Intervention: HFr (3 g fructose · kg(‐1) · d(‐1) and maltodextrin placebo 3 times/d)
Number of subjects: 9
Study: 19444662

Group type: EXPERIMENTAL
Intervention: Healthy MOMS (stress-reduction and social support intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenting Skills for MOMS (parenting skills intervention)
Number of subjects: 0
Study: 17623344

Group type: EXPERIMENTAL
Intervention: Penalized quasi-likelihood (PQL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generalized estimating equations (GEE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed variance estimator from PQL
Number of subjects: 0